About us
Our Objectives
To relieve the need and protect the health of children and their families affected by Spinal Muscular Atrophy (SMA) throughout England & Wales for the public benefit by:
- Working to improve the understanding and knowledge of Spinal Muscular Atrophy (SMA) among the public.
- Providing financial support to further advance clinical research into Spinal Muscular Atrophy (SMA).
Making a Difference: Where Your Donations Go
Rally Round Rupert has been making significant strides in its mission. rough a combination of generous donations and fundraising efforts, we have funded clinical projects that will dramatically improve the lives of those with SMA.
Additional Allocations
RUNFOREMMA (£35,100)
This donation funds projects that support children with serious disabilities
Great Ormond Street Hospital (£23,900)
This donation supports general operations at the hospital.
SMA UK (£19,700)
This allocation contributes to the general operations of SMA UK.
SMA Poland (£500):
This allocation contributes to the general operations of SMA Poland.
St Albans Special Education Needs Department (£100)
This allocation supports the provision of sensory equipment for children with special needs.
Key Allocations
This observational longitudinal study aims to investigate nutritional status, body composition, energy expenditure and dietary habits in infants and children with SMA types I and II treated with the available therapeutic options. The secondary aim is to evaluate the role of body composition and energy metabolism of fat free mass (kcal/kg) as biomarkers to predict response in patients receiving disease-modifying treatments.
Trial to commence October 2024, duration 24 months.
Our Partners:
Great Ormond Street Hospital - LONDON
Department of Food Environmental and Nutritional Sciences (DeFENS)
University of Milan
RUNFOREMMA
A Monocentric, Prospective and Longitudinal study investigating the acceptability, feasibility, safety and efficacy of an optimised rehabilitation program for treated patients with SMA compared to the current rehabilitation program in the United Kingdom.
Trial commenced June 2024. Duration 24 months.
Our Partners:
University of Oxford
We have work in more than 55 countries to strengthen eqaulity
1. Improving Understanding and Knowledge of Spinal Muscular Atrophy (SMA)
a. Public Awareness Campaigns:- Educational Workshops and Seminars: Organize and conduct workshops, webinars, and community seminars aimed at educating the general public, healthcare professionals, and educators about SMA, its symptoms, diagnosis, and available treatments.
- School and Community Outreach: Implement outreach programs in schools, community centers, and local health clinics to provide educational materials and presentations about SMA, aiming to raise awareness from a young age.
- Social Media and Online Content: Develop and distribute engaging online content (videos, articles, infographics) on social media platforms and the charity’s website to inform and educate a broader audience about SMA.
- Collaborations with Media: Partner with local and national media outlets to feature stories, interviews, and public service announcements that highlight the challenges faced by children and families affected by SMA and the importance of early detection and research.
- Public Information Campaigns: Launch targeted campaigns during key awareness months, such as SMA Awareness Month, to spotlight the condition, sharing real-life stories and encouraging the public to learn more and get involved.
- Information Booklets and Brochures: Create and distribute printed and digital materials that explain SMA, its impact on affected families, and the current research and treatment options available.
- Online Resource Hub: Develop an accessible online resource hub on the charity’s website where individuals can find up-to-date information on SMA, support services, and links to further resources.
- Community Support Networks: Establish local support groups and online forums where families affected by SMA can share experiences, information, and provide mutual support.
2. Providing Financial Support for Clinical Research
a. Funding Research Initiatives:- Grants for SMA Research: Offer grants and funding opportunities to research institutions, hospitals, and universities conducting clinical research into SMA. These grants could support various stages of research, from early exploratory studies to advanced clinical trials.
- Collaboration with Research Organizations: Partner with established medical research organizations to co-fund and promote research projects aimed at finding more effective treatments, potential cures, and improving the quality of life for SMA patients.
- Annual Research Conference: Sponsor and organize an annual conference that brings together researchers, healthcare professionals, and stakeholders to share findings, discuss advancements in SMA research, and foster collaboration.
- Patient Participation in Trials: Provide financial assistance to families who wish to participate in clinical trials but are burdened by associated costs (e.g., travel, accommodation, and other expenses). This can help ensure that promising treatments are tested more broadly.
- Awareness and Recruitment: Work with clinical research centers to promote awareness of ongoing trials and assist in recruiting eligible participants, ensuring that research studies have sufficient numbers to generate meaningful data.
- Lobbying for Research Funding: Advocate for increased government and private sector funding for SMA research through lobbying efforts, public petitions, and partnerships with other advocacy organizations.
- Publicizing Research Findings: Help disseminate the results of SMA research to the public and relevant stakeholders, ensuring that new knowledge is shared and applied to improve patient outcomes.